Measles-containing vaccines (MCVs) supply and demand update
An update on measles monovalent and measles and rubella combination vaccines, including supply, demand and anticipated market development through 2025.
Despite available safe and cost-effective vaccines, measles prevalence is increasing with a surge in cases in many regions of the world. This update provides new information on measles and measles and rubella combination vaccines, including supply, demand and anticipated market developments through 2025. It highlights UNICEF's efforts to continue improving demand forecast accuracy and ensure supply is available as countries respond to measles outbreaks and work to recover from the impact of COVID-19 on routine immunization coverage.
Previous updates (2019, 2015, 2014 and 2013) are also available in the scroll down menu.
The impact of increased rates of malnutrition, interruptions to vitamin A supplementation programmes and disruptions to immunization activities are expected to lead to an increase in measles outbreaks. UNICEF calls on countries to eliminate gaps in immunity to reach and sustain over 95 per cent coverage with two measles-containing vaccine doses.